MLEC Stock Overview
A science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Moolec Science SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.87 |
| 52 Week High | US$3.27 |
| 52 Week Low | US$0.77 |
| Beta | -0.55 |
| 11 Month Change | -4.91% |
| 3 Month Change | -26.26% |
| 1 Year Change | -73.39% |
| 33 Year Change | -91.12% |
| 5 Year Change | n/a |
| Change since IPO | -91.13% |
Recent News & Updates
Is Moolec Science (NASDAQ:MLEC) Using Too Much Debt?
Aug 06
Is Moolec Science (NASDAQ:MLEC) A Risky Investment?
Apr 22Shareholder Returns
| MLEC | US Food | US Market | |
|---|---|---|---|
| 7D | -0.2% | 0.3% | 0.07% |
| 1Y | -73.4% | 1.5% | 22.7% |
Return vs Industry: MLEC underperformed the US Food industry which returned 1.5% over the past year.
Return vs Market: MLEC underperformed the US Market which returned 22.7% over the past year.
Price Volatility
| MLEC volatility | |
|---|---|
| MLEC Average Weekly Movement | 8.7% |
| Food Industry Average Movement | 4.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MLEC's share price has been volatile over the past 3 months.
Volatility Over Time: MLEC's weekly volatility has decreased from 16% to 9% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | 45 | Gaston Paladini | moolecscience.com |
Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America.
Moolec Science SA Fundamentals Summary
| MLEC fundamental statistics | |
|---|---|
| Market cap | US$32.68m |
| Earnings (TTM) | -US$7.52m |
| Revenue (TTM) | US$5.01m |
6.5x
P/S Ratio-4.3x
P/E RatioIs MLEC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MLEC income statement (TTM) | |
|---|---|
| Revenue | US$5.01m |
| Cost of Revenue | US$4.61m |
| Gross Profit | US$400.92k |
| Other Expenses | US$7.93m |
| Earnings | -US$7.52m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.20 |
| Gross Margin | 8.01% |
| Net Profit Margin | -150.28% |
| Debt/Equity Ratio | 202.3% |
How did MLEC perform over the long term?
See historical performance and comparison